REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 22nd, 2010 • Igi Laboratories, Inc • Biological products, (no disgnostic substances) • Delaware
This Registration Rights Agreement (this “Agreement”) dated as of December 21, 2010, is made by and among IGI Laboratories, Inc., a Delaware corporation (the “Company”) and Amzak Capital Management, LLC, a limited liability company organized under the laws of the State of Nevada (the “Lender”). All capitalized terms used herein but not otherwise defined shall have the meanings ascribed to such terms in the Credit Agreement.
PLEDGE AND SECURITY AGREEMENTPledge and Security Agreement • December 22nd, 2010 • Igi Laboratories, Inc • Biological products, (no disgnostic substances) • New York
THIS PLEDGE AND SECURITY AGREEMENT, dated as of December 21, 2010 (as the same may from time to time be further amended, restated, supplemented or otherwise modified, this "Agreement"), is entered into by and between IGI Laboratories, Inc a corporation organized and existing under the laws of the State of Delaware (the “Borrower” or the “Grantor” or the “Company”), and Amzak Capital Management, LLC, a limited liability company organized and existing under the laws of the State of Nevada (the “Lender” or “Amzak”).
NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE HEREOF HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY APPLICABLE STATE SECURITIES LAW AND NEITHER MAY BE SOLD OR OTHERWISE...Common Stock Purchase Warrant • December 22nd, 2010 • Igi Laboratories, Inc • Biological products, (no disgnostic substances) • New York
THIS CERTIFIES THAT, FOR VALUE RECEIVED, Amzak Capital Management, LLC, a Nevada limited liability company or its registered assigns (the “Holder”) is entitled to purchase, on the terms and conditions hereinafter set forth, (a) eight hundred eighty one thousand three hundred thirty one (881,331) shares (the “Initial Warrant Shares”) of the Common Stock, $0.01 par value per share (the “Common Stock”), of IGI Laboratories, Inc., a Delaware corporation (the “Company”), at any time in whole or in part from the Original Issue Date (the “Exercise Eligibility Date”) until 5:00 p.m., Eastern Time, on the tenth (10th) anniversary of the Original Issue Date, or if such date is not a day on which the Company is open for business, then the next succeeding day on which the Company is open for business (such date is the “Expiration Date”), but not thereafter, and (b) one percent (1%) of the Fully Diluted Shares of Common Stock (“Conditional Warrant Shares”) of the Company as of the Conditional Warra
CREDIT AGREEMENT Dated as of December 21, 2010 Between IGI LABORATORIES, INC as Borrower and AMZAK CAPITAL MANAGEMENT, LLC as LenderCredit Agreement • December 22nd, 2010 • Igi Laboratories, Inc • Biological products, (no disgnostic substances) • New York
This CREDIT AGREEMENT (the “Agreement”) dated as of December 21, 2010, by and between IGI Laboratories, Inc a corporation organized and existing under the laws of the State of Delaware (the “Borrower”), and Amzak Capital Management, LLC, a limited liability company organized and existing under the laws of the State of Nevada (the “Lender” or “Amzak”). The Borrower and Lender shall collectively be referred to as, the “Parties.”
